Clinical Trial

CGM-Enhanced DPP to Prevent Type 2 Diabetes in Adults With Prediabetes

Study acronym: CGM-DPP
Recruiting
View on ClinicalTrials.gov →
Summary
Prediabetes affects over one-third of adults in the United States, placing them at a higher risk for developing type 2 diabetes and heart disease, which can lead to serious health complications and increased medical costs. Although a program called the Diabetes Prevention Program (DPP) has been shown to lower the risk of diabetes through healthy lifestyle changes, many people find it difficult to stick with these changes over the long term. This study seeks to find out if combining DPP coaching with continuous glucose monitoring (CGM) technology can help people stay on track with their health goals.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-04-25
notable Primary completion pushed: 2028-01-02 -> 2028-03 2026-04-25
minor Completion pushed: 2028-01-02 -> 2028-03 2026-04-25
Trial Details
NCT Number NCT07140848
Lead Sponsor State University of New York at Buffalo
Conditions PreDiabetes
Enrollment 214 participants
Start Date 2026-04-13
Primary Completion 2028-03 (estimated)
Study Completion 2028-03 (estimated)
Updated on ClinicalTrials.gov 2026-04-24